225 related articles for article (PubMed ID: 17370310)
1. Interpreting missense variants: comparing computational methods in human disease genes CDKN2A, MLH1, MSH2, MECP2, and tyrosinase (TYR).
Chan PA; Duraisamy S; Miller PJ; Newell JA; McBride C; Bond JP; Raevaara T; Ollila S; Nyström M; Grimm AJ; Christodoulou J; Oetting WS; Greenblatt MS
Hum Mutat; 2007 Jul; 28(7):683-93. PubMed ID: 17370310
[TBL] [Abstract][Full Text] [Related]
2. Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR).
Chao EC; Velasquez JL; Witherspoon MS; Rozek LS; Peel D; Ng P; Gruber SB; Watson P; Rennert G; Anton-Culver H; Lynch H; Lipkin SM
Hum Mutat; 2008 Jun; 29(6):852-60. PubMed ID: 18383312
[TBL] [Abstract][Full Text] [Related]
3. Detailed computational study of p53 and p16: using evolutionary sequence analysis and disease-associated mutations to predict the functional consequences of allelic variants.
Greenblatt MS; Beaudet JG; Gump JR; Godin KS; Trombley L; Koh J; Bond JP
Oncogene; 2003 Feb; 22(8):1150-63. PubMed ID: 12606942
[TBL] [Abstract][Full Text] [Related]
4. Pathogenicity of MSH2 missense mutations is typically associated with impaired repair capability of the mutated protein.
Ollila S; Sarantaus L; Kariola R; Chan P; Hampel H; Holinski-Feder E; Macrae F; Kohonen-Corish M; Gerdes AM; Peltomäki P; Mangold E; de la Chapelle A; Greenblatt M; Nyström M
Gastroenterology; 2006 Nov; 131(5):1408-17. PubMed ID: 17101317
[TBL] [Abstract][Full Text] [Related]
5. Prediction of missense mutation functionality depends on both the algorithm and sequence alignment employed.
Hicks S; Wheeler DA; Plon SE; Kimmel M
Hum Mutat; 2011 Jun; 32(6):661-8. PubMed ID: 21480434
[TBL] [Abstract][Full Text] [Related]
6. In silico and in vivo splicing analysis of MLH1 and MSH2 missense mutations shows exon- and tissue-specific effects.
Lastella P; Surdo NC; Resta N; Guanti G; Stella A
BMC Genomics; 2006 Sep; 7():243. PubMed ID: 16995940
[TBL] [Abstract][Full Text] [Related]
7. Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing.
Auclair J; Busine MP; Navarro C; Ruano E; Montmain G; Desseigne F; Saurin JC; Lasset C; Bonadona V; Giraud S; Puisieux A; Wang Q
Hum Mutat; 2006 Feb; 27(2):145-54. PubMed ID: 16395668
[TBL] [Abstract][Full Text] [Related]
8. Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristics.
Arnold S; Buchanan DD; Barker M; Jaskowski L; Walsh MD; Birney G; Woods MO; Hopper JL; Jenkins MA; Brown MA; Tavtigian SV; Goldgar DE; Young JP; Spurdle AB
Hum Mutat; 2009 May; 30(5):757-70. PubMed ID: 19267393
[TBL] [Abstract][Full Text] [Related]
9. Prediction of MLH1 and MSH2 mutations in Lynch syndrome.
Balmaña J; Stockwell DH; Steyerberg EW; Stoffel EM; Deffenbaugh AM; Reid JE; Ward B; Scholl T; Hendrickson B; Tazelaar J; Burbidge LA; Syngal S
JAMA; 2006 Sep; 296(12):1469-78. PubMed ID: 17003395
[TBL] [Abstract][Full Text] [Related]
10. Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features.
Belvederesi L; Bianchi F; Loretelli C; Gagliardini D; Galizia E; Bracci R; Rosati S; Bearzi I; Viel A; Cellerino R; Porfiri E
Eur J Hum Genet; 2006 Jul; 14(7):853-9. PubMed ID: 16724012
[TBL] [Abstract][Full Text] [Related]
11. Assessment of pathogenicity criteria for constitutional missense mutations of the hereditary nonpolyposis colorectal cancer genes MLH1 and MSH2.
Genuardi M; Carrara S; Anti M; Ponz de Leòn M; Viel A
Eur J Hum Genet; 1999; 7(7):778-82. PubMed ID: 10573010
[TBL] [Abstract][Full Text] [Related]
12. Novel and recurrent germline alterations in the MLH1 and MSH2 genes identified in hereditary nonpolyposis colorectal cancer patients in Slovakia.
Zavodna K; Bujalkova M; Krivulcik T; Alemayehu A; Skorvaga M; Marra G; Fridrichova I; Jiricny J; Bartosova Z
Neoplasma; 2006; 53(4):269-76. PubMed ID: 16830052
[TBL] [Abstract][Full Text] [Related]
13. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations.
Pistorius S; Görgens H; Plaschke J; Hoehl R; Krüger S; Engel C; Saeger HD; Schackert HK
Cancer Lett; 2007 Apr; 248(1):89-95. PubMed ID: 16837128
[TBL] [Abstract][Full Text] [Related]
14. Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining.
Mangold E; Pagenstecher C; Friedl W; Fischer HP; Merkelbach-Bruse S; Ohlendorf M; Friedrichs N; Aretz S; Buettner R; Propping P; Mathiak M
J Pathol; 2005 Dec; 207(4):385-95. PubMed ID: 16216036
[TBL] [Abstract][Full Text] [Related]
15. Germline MSH2 and MLH1 mutational spectrum including large rearrangements in HNPCC families from Poland (update study).
Kurzawski G; Suchy J; Lener M; Kłujszo-Grabowska E; Kładny J; Safranow K; Jakubowska K; Jakubowska A; Huzarski T; Byrski T; Debniak T; Cybulski C; Gronwald J; Oszurek O; Oszutowska D; Kowalska E; Góźdź S; Niepsuj S; Słomski R; Pławski A; Łacka-Wojciechowska A; Rozmiarek A; Fiszer-Maliszewska Ł; Bebenek M; Sorokin D; Sasiadek MM; Stembalska A; Grzebieniak Z; Kilar E; Stawicka M; Godlewski D; Richter P; Brozek I; Wysocka B; Limon J; Jawień A; Banaszkiewicz Z; Janiszewska H; Kowalczyk J; Czudowska D; Scott RJ; Lubiński J
Clin Genet; 2006 Jan; 69(1):40-7. PubMed ID: 16451135
[TBL] [Abstract][Full Text] [Related]
16. In silico analysis of missense substitutions using sequence-alignment based methods.
Tavtigian SV; Greenblatt MS; Lesueur F; Byrnes GB;
Hum Mutat; 2008 Nov; 29(11):1327-36. PubMed ID: 18951440
[TBL] [Abstract][Full Text] [Related]
17. Germline mutations and polymorphic variants in MMR, E-cadherin and MYH genes associated with familial gastric cancer in Jiangsu of China.
Zhang Y; Liu X; Fan Y; Ding J; Xu A; Zhou X; Hu X; Zhu M; Zhang X; Li S; Wu J; Cao H; Li J; Wang Y
Int J Cancer; 2006 Dec; 119(11):2592-6. PubMed ID: 16929514
[TBL] [Abstract][Full Text] [Related]
18. Ten novel MSH2 and MLH1 germline mutations in families with HNPCC.
Krüger S; Bier A; Plaschke J; Höhl R; Aust DE; Kreuz FR; Pistorius SR; Saeger HD; Rothhammer V; Al-Taie O; Schackert HK
Hum Mutat; 2004 Oct; 24(4):351-2. PubMed ID: 15365996
[TBL] [Abstract][Full Text] [Related]
19. Detection and precise mapping of germline rearrangements in BRCA1, BRCA2, MSH2, and MLH1 using zoom-in array comparative genomic hybridization (aCGH).
Staaf J; Törngren T; Rambech E; Johansson U; Persson C; Sellberg G; Tellhed L; Nilbert M; Borg A
Hum Mutat; 2008 Apr; 29(4):555-64. PubMed ID: 18330910
[TBL] [Abstract][Full Text] [Related]
20. Optimization of experimental conditions for RNA-based sequencing of MLH1 and MSH2 genes.
Jakubowska A; Górski B; Kurzawski G; Debniak T; Hadaczek P; Cybulski C; Kladny J; Oszurek O; Scott RJ; Lubinski J
Hum Mutat; 2001; 17(1):52-60. PubMed ID: 11139242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
